World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
U.K. Pushback on Glaxo Drug Price
Keywords:
Britain's National Institute for Health and Clinical Excellence (NICE) says Glaxo's drug Benlysta for lupus is not "good value for money." The drug is priced at 10,000 pounds a year in the U.K. ($15,600) and much higher at $35,000 a year in the U.S. Benlysta is covered by insurers in the U.S. and some European state run health systems according to Glaxo. NICE also rejected a new multiple sclerosis drug Gilenya, which costs 19,000 pounds a year in the U.K. ($29,700), and $48,000 a year in the U.S.
Britain's National Institute forHealth and Clinical Excellence (NICE) and reviews of drugs for costs and benefits- 2010-2013
10/01/2011
Reviews of drugs for Lupus and MS resulting in turning them down because of high costs and modest efficacy.
Grouped Articles
U.K. Pushback on Glaxo Drug Price
Wall Street Journal 10/01/2011
A grim diagnosis for our ailing U.S. health care system - The Washington Post
Washington Post 11/28/2011
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Cost of Brand-Name Prescription Medicines Soaring
New York Times 11/28/2012
Britain's new 2010 Budget marks a big change from the past.
05/13/2010
The UK Chancellor of the Exchequer, George Osborne, put forward a budget with a 25% spending cut by 2015 in all departments except health and international aid. This marks a huge departure in years of spending by the Labor governments. The new Conservative-Liberal coalition government is determined to take austerity measures to reduce the national debt.
Grouped Articles
Britain's accidental revolution
Economist 05/13/2010
U-Turn in the U.K.: Big Spending Cuts
Wall Street Journal 10/14/2010
Britain Details Radical Spending Cuts, Citing Debt
New York Times 10/20/2010
U.K. Plans New Taxes on Banks, Multinationals
Wall Street Journal 12/04/2014
Tough Slog to Balancing U.K.’s Budget
Wall Street Journal 12/04/2014
Overheard: Digging for Answers on Coal
Wall Street Journal 03/29/2015
Reform of Britain's National Health Service (NHS) in 2010-2011
08/04/2010
Grouped Articles
Britain: Sparing Health Care from Budget Cuts
BusinessWeek 10/14/2010
Britain’s National Health Service, Creaking but Revered, Looms Over Elections
New York Times 04/25/2015
Health Care Reform, British Style
New York Times 08/04/2010
Radical Britain: The unlikely revolutionary
Economist 08/14/2010
Health-care reform: The final frontier
Economist 01/15/2011
Cameron Revises Health Care Overhaul Plan
New York Times 06/14/2011
The UK Conservative government's revamp of the National Health Service- 2011-2012
01/15/2011
Grouped Articles
U.K. Unveils Plans to Revamp Health Service
Wall Street Journal 01/20/2011
David Cameron Proposes Vast Changes in Englandâs Health Service
New York Times 01/19/2011
Health-care reform: The final frontier
Economist 01/15/2011
Cameron Revises Health Care Overhaul Plan
New York Times 06/14/2011
U.K. Ends Health-Service IT Upgrade
Wall Street Journal 09/23/2011
U.K. Pushback on Glaxo Drug Price
Wall Street Journal 10/01/2011
Actions of European regulatory agencies in the pharmaceutical industry.
05/30/2007
The UK Healthcare Regulatory Agency and other European agencies regulating health care, and their actions.
Grouped Articles
Drug Makers Finance Nurses for U.K. Doctors
Wall Street Journal 05/30/2007
U.K. Issues Recall Of Various Generics
Wall Street Journal 07/03/2009
U.K. Pushback on Glaxo Drug Price
Wall Street Journal 10/01/2011
Europe Drug Makers Seek Deal on Crisis Pricing
Wall Street Journal 06/25/2012
The health care models of countries in Europe.
05/02/2005
The German, French, Dutch and other models of health care. The health care system of France covers 99% of 64 million people at acost of 11% of GNP compared to 16% of GNP for the US and 50 million uninsures.
Grouped Articles
German Curbs On Drug Costs Rile Big Brands
Wall Street Journal 05/02/2005
The French Lesson in Health Care
BusinessWeek 06/28/2007
New York Times 07/14/2007
In Holland, Some See Model For U.S. Health-Care System
Wall Street Journal 09/06/2007
Maker of Lipitor Digs In to Fight Generic Rival
New York Times 11/03/2007
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us